Herpes zoster ophthalmicus uveitis: onset and complications: Herpes Zoster Uveitis.

Shingles Uveitis antiviral herpes keratitis zoster

Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 21 09 2023
revised: 08 09 2024
accepted: 12 09 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 22 9 2024
Statut: aheadofprint

Résumé

To describe the timing of uveitis onset and frequency of associated complications in individuals with herpes zoster ophthalmicus (HZO). Retrospective, cohort study METHODS: Individuals with acute HZO seen at the Auckland District Health Board from 2006 to 2016 were studied. The primary outcome measures were the proportion who developed uveitis and time to diagnosis of uveitis following the onset of HZO. Secondary outcome measures included complications of HZO uveitis and effects of prompt antiviral (within 72 hours) on outcomes. 869 patients with HZO were included for analysis, of whom 413 (47.6%) developed uveitis. Median time from onset of rash to diagnosis of uveitis was 10 days (IQR 6 - 14). Of the 658 individuals examined within the first week following rash onset (days 0 through 7), 17.6% (116/658) were diagnosed with uveitis at that initial presenting examination, with an additional 24.9% (164/658) diagnosed with uveitis at a subsequent visit. Complications were higher in eyes with uveitis, including: moderate or severe vision loss, corneal scarring, neurotrophic keratitis, band keratopathy, corneal melt, elevated intraocular pressure, glaucoma, and cataract (all p<0.01). Prompt antiviral was associated with a lower rate of moderate vision loss among eyes with uveitis (p=0.02). Uveitis occurred in approximately half of individuals with HZO and was most frequently diagnosed during the second week following rash onset. Eyes with uveitis were more likely to have other ocular complications and loss of vision.

Identifiants

pubmed: 39307262
pii: S0002-9394(24)00437-9
doi: 10.1016/j.ajo.2024.09.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest No conflict.

Auteurs

Jay J Meyer (JJ)

University of Auckland, Department of Ophthalmology, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: jay_meyer@rocketmail.com.

Kevin Liu (K)

University of Auckland, Department of Ophthalmology, Private Bag 92019, Auckland 1142, New Zealand.

Helen V Danesh-Meyer (HV)

University of Auckland, Department of Ophthalmology, Private Bag 92019, Auckland 1142, New Zealand.

Rachael L Niederer (RL)

University of Auckland, Department of Ophthalmology, Private Bag 92019, Auckland 1142, New Zealand.

Classifications MeSH